is semaglutide or tirzepatide more effective found to be cost-effective than in patients with knee osteoarthritis, obesity Comparing Semaglutide and Tirzepatide for

This is standard pharmaceutical refrigerator range

HbA1c values attained a plateau in the 2 groups of patients receiving CagriSema and semaglutide at 20 weeks, whereas in the cagrinlitide group the decrease in HbA1c was more gradual and was progressive up to the end of treatment at 32 weeks [10]

Obes Rev 2012;13 Suppl 2:30-9.ArticlePubMed 76

According to analysts, the price agreement with the White House may squeeze revenues in the short term, but it significantly expands access to treatment, adding up to 40 million potential US patients eligible for anti-obesity therapy

The limited human research that does exist for these compounds offers inconclusive results